Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Cancer - Volume 51, Issue 8, May 2015, Pages 942-949

Guillem Argilés, Mark P. Saunders, Fernando Rivera, Alberto Sobrero, Al III, Carmen Guillén Ponce, Stefano Cascinu, Eric Van Cutsem, Iain R. Macpherson, Dirk Strumberg, Claus-Henning Köhne, John Zalcberg, Andrea Wagner, Vittorio Luigi Garosi,